BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3141450)

  • 1. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
    Fabbri A; Jannini EA; Ulisse S; Gnessi L; Moretti C; Frajese G; Isidori A
    J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
    Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.
    Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ
    J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of serum immunoreactive luteinizing hormone and bioactive follicle-stimulating hormone by testosterone in early pubertal boys.
    Hassing JM; Padmanabhan V; Kelch RP; Brown MB; Olton PR; Sonstein JS; Foster CM; Beitins IZ
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1082-9. PubMed ID: 2108181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women.
    Matikainen T; Ding YQ; Vergara M; Huhtaniemi I; Couzinet B; Schaison G
    J Clin Endocrinol Metab; 1992 Sep; 75(3):820-5. PubMed ID: 1517372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
    Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
    J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
    Christman GM; Randolph JF; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum LH and FSH responses to synthetic gonadotropin-releasing hormone in normal men.
    Snyder PJ; Reitano JF; Utiger RD
    J Clin Endocrinol Metab; 1975 Nov; 41(5):938-45. PubMed ID: 1102556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that androgen negative feedback regulates hypothalamic gonadotropin-releasing hormone impulse strength and the burst-like secretion of biologically active luteinizing hormone in men.
    Veldhuis JD; Urban RJ; Dufau ML
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1227-35. PubMed ID: 1592863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsatile bioactive luteinizing hormone secretion in men with chronic renal failure and following renal transplantation.
    Talbot JA; Rodger RS; Robertson WR
    Nephron; 1990; 56(1):66-72. PubMed ID: 2122267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pulsatile secretion of bioactive luteinising hormone in normal adult men.
    Talbot JA; Rodger RS; Shalet SM; Littley MD; Robertson WR
    Acta Endocrinol (Copenh); 1990 May; 122(5):643-50. PubMed ID: 2112817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteinizing hormone, follicle stimulating hormone and testosterone in normal and impotent men following LHRH and HCG stimulation.
    Delitala G; Masala A; Alagna S; Lotti G
    Clin Endocrinol (Oxf); 1977 Jan; 6(1):11-15. PubMed ID: 321154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of testosterone infusion and naloxone on luteinizing hormone secretion in normal men.
    Kletter GB; Foster CM; Beitins IZ; Marshall JC; Kelch RP
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1215-9. PubMed ID: 1430081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing hormone pulsatility in men with damage to the germinal epithelium.
    Talbot JA; Shalet SM; Tsatsoulis A; Grabinski M; Robertson WR
    Int J Androl; 1990 Jun; 13(3):223-31. PubMed ID: 2387642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked suppression of gonadotropins and testosterone by an antagonist analog of gonadotropin-releasing hormone in men.
    Salameh W; Bhasin S; Steiner B; McAdams LA; Peterson M; Swerdloff R
    Fertil Steril; 1991 Jan; 55(1):156-64. PubMed ID: 1898888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects.
    Spinder T; Spijkstra JJ; van den Tweel JG; Burger CW; van Kessel H; Hompes PG; Gooren LJ
    J Clin Endocrinol Metab; 1989 Jul; 69(1):151-7. PubMed ID: 2471710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteinizing hormone and follicle-stimulating hormone secretory dynamics in Turner's syndrome.
    Boyar RM; Ramsey J; Chipman J; Fevre M; Madden J; Marks JF
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1078-83. PubMed ID: 122419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced 'gonadotrophin response to releasing hormone' after chronic administration to impotent men.
    Davies TF; Gomez-Pan A; Watson MJ; Mountjoy CQ; Hanker JP; Besser GM; Hall R
    Clin Endocrinol (Oxf); 1977 Mar; 6(3):213-8. PubMed ID: 322894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary hypogonadism in older men: its relation to impotence.
    Korenman SG; Morley JE; Mooradian AD; Davis SS; Kaiser FE; Silver AJ; Viosca SP; Garza D
    J Clin Endocrinol Metab; 1990 Oct; 71(4):963-9. PubMed ID: 2205629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoactive inhibin as a marker of Sertoli cell function following cytotoxic damage to the human testis.
    Tsatsoulis A; Shalet SM; Morris ID; de Kretser DM
    Horm Res; 1990; 34(5-6):254-9. PubMed ID: 2129227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.